Company release
Nanoform Finland Plc
April 8, 2024
09.00 Finnish time / 08.00 Swedish time
Nanoform Finland Plc: Certified Adviser change to Carnegie Investment Bank Ab
The shares of Nanoform Finland Plc are listed for trading on Nasdaq First North Premier Growth Market Finland maintained by Nasdaq Helsinki Ltd and Nasdaq First North Premier Growth Market Sweden maintained by Nasdaq Stockholm Ltd, which require the nomination of a Certified Adviser.
Effective April 10, 2024, the Certified Adviser to Nanoform Finland Plc is Carnegie Investment Bank Ab (publ). The Certified Adviser to Nanoform Finland Plc until April 9, 2024, is Danske Bank A/S, Finland Branch.
For further information, please contact:
Peter Hänninen, General Counsel
peter.hanninen@nanoform.com, +358 50 353 0408
For investor relations queries, please contact:
Henri von Haartman, Director of Investor Relations
hvh@nanoform.com, +46 7686 650 11
About Nanoform
Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services, from pre-formulation to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 744 1900. For more information, please visit www.nanoform.com.